Seeking Alpha

Ocular Therapeutix beats by $0.16, revenue in-line

  • Ocular Therapeutix (NASDAQ:OCUL): Q2 EPS of -$2.10 beats by $0.16.
  • Revenue of $0.1M in-line.
  • Press Release
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector